360 Capital holds EUR 45m first close on early stage tech fund
Early-stage venture capital firm 360 Capital has held a first close on its second French seed strategy at EUR 45m.
More on Venture
VC Profile: Target Global assesses B2B opportunities in final stretch of current fund deployment
Nearing full deployment for its second growth fund, pan-European VC firm outlines plans to back defensive B2B models and institutionalise its co-investment strategy and LP base
EQT closes LSP Dementia on EUR 260m hard cap
Series A-focused fund exceeded its EUR 100m target and extended fundraising after increased LP interest in its strategy
Newton Biocapital heads for year-end close for second, EUR 150m life sciences fund
Belgian-Japanese VC has raised EUR 50m to date and is lining up exits from its debut fund
Sofinnova launches digital medicine strategy
Life sciences sponsor’s sixth strategy will deploy EUR 2m-EUR 8m tickets in seed and Series A
Latest News
Ardian acquires Mimacom Flowable Group
GP will invest alongside management to drive growth for Swiss software and IT consultancy through acquisitions
VC Profile: Target Global assesses B2B opportunities in final stretch of current fund deployment
Nearing full deployment for its second growth fund, pan-European VC firm outlines plans to back defensive B2B models and institutionalise its co-investment strategy and LP base
Large-cap sponsors circle Qiagen bioinformatics arm ahead of indicative bids
Potential PE bidders are assessing performance and market share of the Netherlands-headquartered business
Riverside acquires Dastex and Vita Verita
Sponsor plans to pursue a buy-and-build strategy for new European clean room contamination control group